6) While the new AEDs are not superior to traditional AEDs in terms of their antiepileptic- and acute adverse effects, 7 9) their prolonged administration elicited fewer adverse effects and milder interactions with other drugs than did traditional AEDs. 10 13) Most new AEDs involve less teratogenicity and their effect on the patients
The administration of antiepileptic drugs (AEDs) is the first treatment of epilepsy, one of the most common neurological diseases. Therapeutic guidelines include newer AEDs as front-line drugs; monotherapy with new AEDs is delivered in Japan. While about
Substitute antiepileptic drugs (AEDs) To encounter unmet therapeutic needs, new approaches to traditional antiepileptic drug (AED) research and development are
6) While the new AEDs are not superior to traditional AEDs in terms of their antiepileptic- and acute adverse effects, 7 9) their prolonged administration elicited fewer adverse effects and milder interactions with other drugs than did traditional AEDs. 10 13) Most new AEDs involve less teratogenicity and their effect on the patients
Recently, many new antiepileptic drugs (AEDs) have been devel-oped, which has led to additional options for the care of patients with epilepsy. New AEDS are needed because there are still patients with epilepsy that is refractory to established AEDs. Furthermore, there is a need for new AEDs without pharmacokinetic drug interactions, drugs
The administration of antiepileptic drugs (AEDs) is the first treatment of epilepsy, one of the most common neurological diseases. Therapeutic guidelines include newer AEDs as front-line drugs; monotherapy with new AEDs is delivered in Japan. While about
by A Reimers 2024 Cited by 55Since 2024, sixteen new antiepileptic drugs (AEDs) have been introduced. Most of these new AEDs have only been insufficiently studied with
The administration of antiepileptic drugs (AEDs) is the first treatment of epilepsy, one of the most common neurological diseases. Therapeutic guidelines include newer AEDs as front-line drugs; monotherapy with new AEDs is delivered in Japan. While about
Antiepileptic drugs (AEDs) are the mainstay of epilepsy treatment and, after many years in which there was essentially little progress in terms of developing new epilepsy drug treatments, 2024 began the era of new AEDs, so that during 2024 2024, 16 new AEDs were licensed for clinical use.
Comments